Huejejjr_老虎社区_美港股上老虎

Carrotcake
2021-06-29

Huejejjr

Moderna’s Covid Shot Gets Regulatory Nod in India for Imports

Indemnity details still being discussed, official says India has fully vaccinated only 4% of its pop

Moderna’s Covid Shot Gets Regulatory Nod in India for Imports

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":159457683,"tweetId":"159457683","gmtCreate":1624977945042,"gmtModify":1633946247403,"author":{"id":3573166225931101,"idStr":"3573166225931101","authorId":3573166225931101,"authorIdStr":"3573166225931101","name":"Carrotcake","avatar":"https://static.tigerbbs.com/afb7b52104c648bff57fa67033090329","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>&nbsp; Huejejjr</p></body></html>","htmlText":"<html><head></head><body><p>&nbsp; Huejejjr</p></body></html>","text":"Huejejjr","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/159457683","repostId":1144845089,"repostType":4,"repost":{"id":"1144845089","kind":"news","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=full","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":1471,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":8,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}